Electra Therapeutics Inc.

NASDAQ: ETRA · Healthcare · Medical - Pharmaceuticals

PublicHQ South San Francisco, CAReports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 36

v0.1 · 5/100 weight · pillars only

↑ market scale, listing tenure · ↓ listing tenure, market scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-09-19

Market cap

$281.1M

as of 2026-09-19

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Electra Therapeutics Inc.’s financial profile?

Electra Therapeutics Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Mobia Medical, Inc. Common Stock——Indaptus Therapeutics, Inc.——Sionna Therapeutics, Inc.——Galectin Therapeutics Inc.——Anavex Life Sciences Corp.——Atrium Therapeutics, Inc.——

Key facts

CEO—

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersSouth San Francisco, CA

ExchangeNASDAQ: ETRA

Employees—

IPO date2026-09-18

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.